Macular Degeneration, Senile
3
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
6 treatments under study, led by Fundus Autofluorescence Imaging
Research Leaders
6 sponsors active, led by Fondazione G.B. Bietti, IRCCS
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
33.3%
1 terminated out of 3 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration
Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients
Research Network
Common Treatments
- Fundus Autofluorescence Imaging1
- Color Retinography1
- Retimax Vision Trainer1
- Pascal Synthesis 577 Sham Topcon Corporation Tokyo Japan1
- Pascal Synthesis 577 Subthreshold Laser Topcon Corporation Tokyo Japan1
Active Sponsors
- Fondazione G.B. Bietti, IRCCS1
- University of Modena and Reggio Emilia1
- Fondation Ophtalmologique Adolphe de Rothschild1
- University of Rome Tor Vergata1
- Ospedale San Raffaele1
Top Investigators
Fondation Ophtalmologique A. de Rothschild
Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa -UNIMORE- University of Modena and Reggio Emilia
Related Conditions
- Macular Degeneration Dry2
- Macular Scar1
- Macular Degeneration Advanced1
- Macular Degeneration Nonexudative1
- Laser Burn Of Retina1